Live Breaking News & Updates on Division Of Hematology Medical Oncology

Stay updated with breaking news from Division of hematology medical oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kummar on the Investigation of Rezatapopt in TP53 Y220C–Mutated Advanced Solid Tumors

Kummar on the Investigation of Rezatapopt in TP53 Y220C–Mutated Advanced Solid Tumors
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United States , Shivaani Kummar , Courtney Flaherty , Knight Cancer Institute , Cancer Research , Division Of Hematology Medical Oncology , Oregon Health Science University School Of Medicine , Live On Air , Lester Dearmond Endowed Chair , Medical Oncology , Oregon Health , Science University School , Experimental Therapeutics , Knight Cancer , Onclive On Air , Apple Podcasts , Google Podcasts , Amazon Music ,

Rezatapopt Revolutionizes Research Directions in TP53-Mutated Solid Tumors

Shivaani Kummar, MBBS, FACP, discusses the mechanism of action of the TP53-directed agent rezatapopt and efficacy data with this agent in solid tumors. ....

United States , San Diego , Shivaani Kummar , Division Of Hematology Medical Oncology , Pharmaceuticals Inc , Cancer Research , Oregon Health Science University School Of Medicine , International Conference On Molecular , Knight Cancer Institute , Lester Dearmond Endowed Chair , Medical Oncology , Oregon Health , Science University School , Experimental Therapeutics , Knight Cancer , Molecular Targets ,

Dr Kummar on the Evaluation of Rezatapopt in Advanced Solid Tumors

Shivaani Kummar, MD, FACP, discusses the evaluation of rezatapopt in patients with advanced solid tumors. ....

United States , Shivaani Kummar , Division Of Hematology Medical Oncology , Oregon Health Science University School Of Medicine , International Conference On Molecular , Knight Cancer Institute , Cancer Research , Division Head , Lester Dearmond Endowed Chair , Medical Oncology , Oregon Health , Science University School , Experimental Therapeutics , Molecular Targets , Cancer Therapeutics , Patients With Advanced Solid Tumors ,

Orca-T Shows Promise in Intermediate-/High-Risk MDS

The stem cell thrapy, Orca-T led to promising relapse-free and overall survival rates in patients with intermediate- to high-risk myelodysplastic syndrome. ....

United States , Arpita Gandhi , American Society Of Hematology Annual Meeting , Molecular International Prognostic Scoring System , Oregon Health , Division Of Hematology Medical Oncology , Science University , International Expert Panel , School Of Medicine , Hematology Annual , Medical Oncology , Expert Panel ,

Jasper Therapeutics Presents Positive Final Results from

Jasper Therapeutics Presents Positive Final Results from
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United States , San Diego , Lauren Barbiero , Edwin Tucker , Rajni Agarwal , John Mullaly , Arpita Gandhi , Alex Gray , Division Of Hematology Medical Oncology , America Society Of Hematology , Jasper Therapeutics Inc , Division Of Stem Cell Transplantation , Oregon Health Science University School Of Medicine , Assistant Professor , Medical Oncology , Oregon Health , Science University School , America Society , Transplant Day , Stem Cell Transplantation , Stanford Medicine , Fanconi Anemia , Chief Medical Officer , Chronic Spontaneous Urticaria , Chronic Inducible Urticaria , Intermediate Risk ,